Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991991 · ClinicalTrials.gov registry record
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00991991 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants.
The verdict
NCT00991991 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients with stage I, stage II, or stage III malignant melanoma.
Interventions
- GENETIC gene expression analysis
- OTHER medical chart review
- GENETIC polymerase chain reaction
- GENETIC polymorphism analysis
- OTHER matrix-assisted laser desorption/ionization time of flight mass spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991991
The ClinicalTrials.gov registry entry for NCT00991991 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00991991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991991 about?
NCT00991991 is a clinical study titled "Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma". RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients with stage I, stage II, or stage III malignant melanoma.
What is the current status of trial NCT00991991?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2009-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00991991?
The interventions under investigation include: gene expression analysis (GENETIC), medical chart review (OTHER), polymerase chain reaction (GENETIC), polymorphism analysis (GENETIC), matrix-assisted laser desorption/ionization time of flight mass spectrometry (OTHER).
Who is sponsoring clinical trial NCT00991991?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.